ACRAL PEELING SKIN SYNDROME

This adverse event was reported 23 times

These drugs are most commonly taken by patients reporting ACRAL PEELING SKIN SYNDROME:

# Drug Count
0 BEVACIZUMAB 12
1 FLUOROURACIL 7
2 FLUOROURACIL CREAM, 0.5% 7
3 CAPECITABINE 5
4 DOCETAXEL 5
5 DOCETAXEL ANHYDROUS 5
6 INSULIN 5
7 OXALIPLATIN 5
8 CYCLOPHOSPHAMIDE 4
9 CYCLOPHOSPHAMIDE FOR INJECTION 4
See all common drugs associated with ACRAL PEELING SKIN SYNDROME

ACRAL PEELING SKIN SYNDROME is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 LEVOLEUCOVORIN INJECTION 1 0.0003
1 DEFIBROTIDE SODIUM 1 0.0003
2 LEVOLEUCOVORIN 1 0.0003
3 BEVACIZUMAB 12 0.0001
4 FLUOROURACIL CREAM, 0.5% 7 0.0001
5 FLUOROURACIL 7 0.0001
6 TEDUGLUTIDE 1 0.0001
7 DOCETAXEL 5 0.0001
8 DOCETAXEL ANHYDROUS 5 0.0001
9 OXALIPLATIN 5 0.0001
See all drugs enriched for association with ACRAL PEELING SKIN SYNDROME

ACRAL PEELING SKIN SYNDROME is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 GLP-2 Analog [EPC] 1 0.0001
1 Vascular Endothelial Growth Factor Inhibitor [EPC] 12 0.0001
2 HER2/neu Receptor Antagonist [EPC] 4 0.0001
3 Nucleoside Metabolic Inhibitor [EPC] 9 0.0000
4 Microtubule Inhibitor [EPC] 5 0.0000
5 Platinum-based Drug [EPC] 6 0.0000
6 Folate Analog [EPC] 1 0.0000
7 Vitamin A [EPC] 1 0.0000
8 Methylxanthine [EPC] 1 0.0000
9 Alkylating Drug [EPC] 4 0.0000
See all drug classes enriched for association with ACRAL PEELING SKIN SYNDROME